RAS Peptide Profiles in Patients With Arterial Hypertension
NCT02449811
·
clinicaltrials.gov ↗
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Essential Hypertension
Interventions
DRUG:
Perindopril
DRUG:
Olmesartan
DRUG:
Amlodipine
DRUG:
Hydrochlorothiazide
Sponsor
Insel Gruppe AG, University Hospital Bern